cost effectiveness
Precision Oncology Drugmakers Are the IRA's Staunchest Adversaries—And They're Not Backing Down
Premium
Medicare price negotiations officially began this week, but drugmakers are determined to challenge the law's constitutionality in front of the highest court.
Precision Oncology Drugs Cost $1B Less to Develop Than Traditional Therapies, Study Suggests
Premium
Researchers suggested that the savings companies incur by using a precision medicine approach could be reinvested to improve access to companion tests and ensure equitable drug pricing.
Sickle Cell Gene Therapies Lovo-Cel, Exa-Cel Could Be Cost Effective at $2M, ICER Finds
The FDA is expected to issue decisions on Bluebird Bio's gene therapy and Vertex Pharmaceuticals and CRISPR Therapeutics' drug in December.
NICE Recommends Novartis' Tafinlar-Mekinist as Frontline Treatment for BRAF-Mutant NSCLC
The agency estimated that the drug combination's cost-effectiveness falls within what it considers an acceptable use of the NHS's resources.
Biogen, Eisai's Leqembi Priced Too High to Be Cost Effective, ICER Finds
The Institute for Clinical and Economic Review determined that Leqembi's $26,500 list price would need to drop between 19 percent to 66 percent to be cost effective.